Clinical Trial

To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer

Study acronym: HyPROS-LC
Recruiting
View on ClinicalTrials.gov →
Summary
This study was a single-center, single-arm clinical study to evaluate the safety and efficacy of hypervision proton surgery with single large fractionated doses (34GyE and 39GyE) in the treatment of early peripheral NSCLC.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-25.
Status change: Not Yet Recruiting → Recruiting 2026-04-07
Trial Details
NCT Number NCT07195084
Lead Sponsor Anhui Provincial Cancer Hospital
Collaborators: Anhui Provincial Hospital
Conditions Non-Small Cell Lung Cancer
Enrollment 12 participants
Start Date 2025-09-20
Primary Completion 2027-09-19 (estimated)
Study Completion 2028-09-19 (estimated)
Updated on ClinicalTrials.gov 2026-04-13